(Q45236679)

English

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

scientific article published in February 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

phase II clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

M M Borner

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

J Bernhard

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

D Dietrich

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

R Popescu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

M Wernli

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

P Saletti

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

D Rauch

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

R Herrmann

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

D Koeberle

9

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

H Honegger

10

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

P Brauchli

11

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

D Lanz

12

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

A D Roth

13

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland

14

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

282-288

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Clinical relevance of single item quality of life indicators in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI047

21 January 2018

Identifiers

10.1093/ANNONC/MDI047

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45236679&oldid=2070937060"